Table 1 Definition and quantification of variables
From: Cost comparison of MRSA screening and management – a decision tree analysis
Variable | Description | Average value | Min value | Max value | References |
|---|---|---|---|---|---|
P t | MRSA prevalence of all inpatients | 3.08% | 1.20% | 5.30% | [12] |
P r | MRSA prevalence of high-risk inpatients | 11.94% | 3.85% | 20.6% | [12] |
P n.i. | MRSA prevalence of patients without indication for a targeted screening | 0.03% | 0.03% | 0.03% | [13] |
RT no iso | Rate of MRSA transmission not in isolation per day | 0.029 | 0.0014 | 0.1400 | [12] |
RT iso | Rate of MRSA transmission in isolation per day | 0.003 | 0.0008 | 0.0090 | [12] |
Sen PCR | Sensitivity of PCR method | 91.09% | 62.50% | 100% | [12] |
Sen cul | Sensitivity of culture method | 88.73% | 53.00% | 100% | [12] |
SP PCR | Specificity of PCR method | 95.79% | 83.70% | 100% | [12] |
SP cul | Specificity of culture method | 93.23% | 68.00% | 100% | [12] |
| Average costs for pre-emptive isolation per day | 62.77 € | 9.45 € | 145.11 € | [12] |
| Average costs per MRSA case per day | 506.92 € | 213.51 € | 1,411.44 € | [12] |
∅ LOS MRSA | Average length of stay of MRSA patients in days | 24.88 | 18 | 39 | [12] |